fbpx
NZCR News

NZCR's Professor Ed Gane is a world leading researcher. His recent research of Hepatitis B in Japanese and Non Japanese subjects has recently been published in Anti Viral Therapy

NZCR News

The life of a participant in clinical trials in NZ gives individuals the opportunity to take part in research that could improve many people's lives. Participating in a clinical trial in NZ can vary depending on the type of trial and its objectives, and medical trials can be from one day to up to 18 days with follow-up visits.

NZCR News

Clinical trials in NZ are designed to advance global health, and usually are part of a multi-country trial approach. At NZCR , our clinical research teams’ partner with leading medical researchers, doctors and science experts to help develop innovative medicines and treatments that improve people's lives.

NZCR News

NZCR Clinical Trial - Universe Study showing exciting results

NZCR News

Hope offered by new ALS research findings

NZCR News

NZCR and Verve Therapeutics - Gene Editing Study includes first patient in Auckland New Zealand.

NZCR News

Our research partner Alvotech has announced positive results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara® conducted at NZCR research facilities.

NZCR News

NZCR Lead Research Physician Dr Alexandra Cole, CEO Dr Christian Schwabe and Business Development Manager, Marcus Burrows are pleased to be representing NZCR at ARCS 2022 in Sydney this week.

NZCR News

New Zealand Clinical Research (NZCR) is putting put out a call for healthy males in Auckland and Christchurch to be part of two large trials researching potential new treatments for breast cancer.

NZCR News

A randomized, adaptive design, double-blind, 3-arm, parallel study assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab
biosimilar, in healthy adult subjects

NZCR News

NZCR is reducing medical waste and helping the Pacific Islands at the same time

NZCR News

NZCR staff received a lovely surprise this week.